JESSICA MATTHEWS: Open Payments
NPI 1831850130 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,905 in 57 payments from 20 companies in 2025. Trend: 2023 $10,492 · 2024 $3,299 · 2025 $1,905
Food & beverage: $1,814Education: $80Speaker / faculty: $12
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 9 | $235 |
| Neurelis, Inc. | 4 | $154 |
| Lundbeck LLC | 4 | $144 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $140 |
| ACADIA Pharmaceuticals Inc | 4 | $136 |
| MDD US Operations, LLC | 10 | $136 |
| Neurocrine BioSciences, Inc. | 2 | $118 |
| PFIZER INC. | 2 | $101 |
| Amgen Inc. | 1 | $96 |
| SpringWorks Therapeutics, Inc. | 4 | $95 |
Products named: VUMERITY, VALTOCO, VYEPTI, CAPLYTA, NUPLAZID, EVENITY, INGREZZA, ZEPBOUND.
Industry payments across AR — which companies pay providers there.
